Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES GLAND PHARMA ZIM LABORATORIES/
GLAND PHARMA
 
P/E (TTM) x 39.0 53.5 73.0% View Chart
P/BV x 1.5 10.2 15.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   GLAND PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
GLAND PHARMA
Mar-21
ZIM LABORATORIES/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs1312,784 4.7%   
Low Rs531,701 3.1%   
Sales per share (Unadj.) Rs189.2211.7 89.4%  
Earnings per share (Unadj.) Rs4.560.9 7.4%  
Cash flow per share (Unadj.) Rs14.267.0 21.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs99.0359.3 27.5%  
Shares outstanding (eoy) m16.24163.59 9.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.510.6 4.6%   
Avg P/E ratio x20.536.8 55.6%  
P/CF ratio (eoy) x6.533.5 19.3%  
Price / Book Value ratio x0.96.2 14.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,497366,894 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3583,114 11.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,07334,629 8.9%  
Other income Rs m231,348 1.7%   
Total revenues Rs m3,09635,977 8.6%   
Gross profit Rs m34613,022 2.7%  
Depreciation Rs m158988 16.0%   
Interest Rs m10934 319.5%   
Profit before tax Rs m10213,348 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m293,378 0.9%   
Profit after tax Rs m739,970 0.7%  
Gross profit margin %11.337.6 29.9%  
Effective tax rate %28.525.3 112.5%   
Net profit margin %2.428.8 8.3%  
BALANCE SHEET DATA
Current assets Rs m1,91851,236 3.7%   
Current liabilities Rs m1,4205,125 27.7%   
Net working cap to sales %16.2133.2 12.2%  
Current ratio x1.410.0 13.5%  
Inventory Days Days168 185.4%  
Debtors Days Days85871 1,213.6%  
Net fixed assets Rs m1,30413,724 9.5%   
Share capital Rs m162164 99.3%   
"Free" reserves Rs m1,44558,615 2.5%   
Net worth Rs m1,60858,778 2.7%   
Long term debt Rs m21839 554.9%   
Total assets Rs m3,22264,961 5.0%  
Interest coverage x1.9392.3 0.5%   
Debt to equity ratio x0.10 20,289.2%  
Sales to assets ratio x1.00.5 178.9%   
Return on assets %5.715.4 36.7%  
Return on equity %4.617.0 26.8%  
Return on capital %11.622.8 50.9%  
Exports to sales %67.483.8 80.5%   
Imports to sales %4.10-   
Exports (fob) Rs m2,07229,021 7.1%   
Imports (cif) Rs m127NA-   
Fx inflow Rs m2,14029,021 7.4%   
Fx outflow Rs m12716,878 0.8%   
Net fx Rs m2,01212,142 16.6%   
CASH FLOW
From Operations Rs m3196,049 5.3%  
From Investments Rs m-59-15,240 0.4%  
From Financial Activity Rs m-26012,385 -2.1%  
Net Cashflow Rs m-13,230 -0.0%  

Share Holding

Indian Promoters % 33.3 0.0 -  
Foreign collaborators % 0.0 58.0 -  
Indian inst/Mut Fund % 0.0 23.0 -  
FIIs % 0.0 11.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 42.0 158.9%  
Shareholders   3,646 109,097 3.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

GLAND PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GLAND PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLAND PHARMA. Also includes updates on the valuation of GLAND PHARMA.

Gland Pharma Q4 Results: Net Profit Rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Jan 20, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS